Amplitude control of protein kinase C by RINCK, a novel E3 ubiquitin ligase

Dan Chen1, Christine Gould2, Renee Garza3

  • 1Department of Pharmacology, University of California at San Diego, La Jolla, California, 92093-0721; Molecular Pathology Graduate Program, University of California at San Diego, La Jolla, California, 92093-0721.

Insights

Researchers discovered RINCK, an E3 ligase, which targets Protein Kinase C (PKC) for degradation. This finding reveals a new mechanism for controlling PKC signaling amplitude, crucial for cellular processes and disease states like cancer.

Area of Science:

  • Molecular Biology
  • Cellular Signaling
  • Biochemistry

Background:

  • Protein Kinase C (PKC) isozymes are critical regulators of cellular signaling pathways.
  • Dysregulation of PKC levels is implicated in various diseases, including cancer.
  • Mechanisms governing PKC protein turnover remain largely uncharacterized.

Purpose of the Study:

  • To identify novel proteins involved in the regulation of PKC protein levels.
  • To elucidate the mechanism of PKC degradation and its role in cellular signaling.

Main Methods:

  • Yeast two-hybrid screening to identify interacting proteins with PKCbeta.
  • Co-immunoprecipitation assays to confirm cellular association between RINCK and PKC.
  • In vitro and in-cell ubiquitination assays to assess RINCK's ligase activity.
  • Overexpression and genetic knockdown studies to evaluate RINCK's effect on PKC levels.

Main Results:

  • Identification of RINCK (RING-finger protein that interacts with C kinase), a TRIM family E3 ligase.
  • RINCK directly interacts with PKC isozymes via the PKC C1 domain.
  • RINCK catalyzes the ubiquitination and subsequent degradation of PKC, regulating its cellular levels across all isozymes.
  • RINCK-mediated degradation is independent of phorbol ester-induced down-regulation.

Conclusions:

  • RINCK acts as a novel E3 ligase that targets PKC for ubiquitin-mediated degradation.
  • This pathway provides a new mechanism for controlling the amplitude of PKC signaling.
  • The discovery offers insights into PKC regulation relevant to cancer and other disease states.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...